U.S. markets close in 2 hours 18 minutes

Todos Medical Ltd. (TOMDF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0560-0.0030 (-5.08%)
As of 1:25PM EDT. Market open.

Todos Medical Ltd.

1 Hamada Street
Rehovot 7670301
Israel
972 52 642 0126
http://todosmedical.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees3

Key Executives

NameTitlePayExercisedYear Born
Mr. Rami ZigdonCo-Founder & Chief Bus. Officer94kN/A1962
Mr. Gerald E. CommissiongCEO, Pres & DirectorN/AN/A1983
Mr. Daniel HirschCFO & DirectorN/AN/A1969
Ms. Priyanka MisraVP of Corp. Devel.N/AN/AN/A
Dr. Jorge A. LeonChief Medical AdvisorN/AN/AN/A
Amounts are as of December 31, 2019 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Todos Medical Ltd., a clinical-stage medical diagnostics company, develops and commercializes blood tests for the detection of immune-related diseases in Israel and internationally. The company develops Total Biochemical Infrared Analysis method, a proprietary method for screening of solid tumors using peripheral blood spectroscopy analysis; and blood tests for the detection of neurodegenerative disorders, such as Alzheimer's disease. Its cancer screening and diagnosis product includes TM-B1 and TM-B2 for breast cancer blood tests; and TM-C1 for testing of colorectal cancer. The company also imports and distributes personal protective equipment, test kits, and medical devices, such as ventilators. Todos Medical Ltd. has partnership with Moto-Para and Meridian HSN to provide a complete turnkey solution for on-site COVID testing. Todos Medical Ltd. was founded in 2010 and is headquartered in Rehovot, Israel.

Corporate Governance

Todos Medical Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.